Journal ArticleOPEN ACCESS

Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion

Hematology, Transfusion and Cell Therapy (2018) 40(3) 267-273
DOI: 10.1016/j.htct.2018.05.011
2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Velloso, E. D. R. P., Magalhães, S. M. M., Chauffaille, M. de L. L. F., Buzzini, R., & Bernardo, W. M. (2018). Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion. Hematology, Transfusion and Cell Therapy, 40(3), 267–273. https://doi.org/10.1016/j.htct.2018.05.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free